-+ 0.00%
-+ 0.00%
-+ 0.00%

AARDVARK THERAPEUTICS ANNOUNCES FDA HAS LIFTED THE CLINICAL HOLD ON ARD-101 FOR THE TREATMENT OF PRADER-WILLI SYNDROME AND WILL HOST WEBCAST TO REVIEW THE AVAILABLE EXPLORATORY PHASE 3 HERO/OLE DATA

Reuters·10/22/2026 20:13:22

Please log in to view news